Arkolith/Insider Trading/AMAM/Form 4

Cormorant Asset Management, LP

10% OwnerAmbrx Biopharma, Inc. (AMAM) · full profile →Form 4 · filed Oct 25, 2023
Net Buying
Open-Market Buys
$9.1M
Open-Market Sells
$0
Net Open-Market Flow
$9.1M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 23, 2023Buy(P)1.3M$6.99$9.1M11.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-002829) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML